JACS Au (Jun 2024)
Cyclic Peptides KS-133 and KS-487 Multifunctionalized Nanoparticles Enable Efficient Brain Targeting for Treating Schizophrenia
- Kotaro Sakamoto,
- Seigo Iwata,
- Zihao Jin,
- Lu Chen,
- Tatsunori Miyaoka,
- Mei Yamada,
- Kaiga Katahira,
- Rei Yokoyama,
- Ami Ono,
- Satoshi Asano,
- Kotaro Tanimoto,
- Rika Ishimura,
- Shinsaku Nakagawa,
- Takatsugu Hirokawa,
- Yukio Ago,
- Eijiro Miyako
Affiliations
- Kotaro Sakamoto
- Research & Development Department, Ichimaru Pharcos Company Limited, Motosu, Gifu, Japan
- Seigo Iwata
- Graduate School of Advanced Science and Technology, Japan Advanced Institute of Science and Technology, Nomi, Ishikawa, Japan
- Zihao Jin
- Laboratory of Biopharmaceutics, Osaka University, Suita, Osaka, Japan
- Lu Chen
- Laboratory of Biopharmaceutics, Osaka University, Suita, Osaka, Japan
- Tatsunori Miyaoka
- Laboratory of Biopharmaceutics, Osaka University, Suita, Osaka, Japan
- Mei Yamada
- Laboratory of Biopharmaceutics, Osaka University, Suita, Osaka, Japan
- Kaiga Katahira
- Laboratory of Biopharmaceutics, Osaka University, Suita, Osaka, Japan
- Rei Yokoyama
- Department of Cellular and Molecular Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Hiroshima, Japan
- Ami Ono
- Department of Cellular and Molecular Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Hiroshima, Japan
- Satoshi Asano
- Department of Cellular and Molecular Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Hiroshima, Japan
- Kotaro Tanimoto
- Department of Orthodontics and Craniofacial Developmental Biology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Hiroshima, Japan
- Rika Ishimura
- Center for Supporting Drug Discovery and Life Science Research, Graduate School of Pharmaceutical Science, Osaka University, Suita, Osaka, Japan
- Shinsaku Nakagawa
- Laboratory of Biopharmaceutics, Osaka University, Suita, Osaka, Japan
- Takatsugu Hirokawa
- Division of Biomedical Science, Institute of Medicine, University of Tsukuba, Tsukuba, Japan
- Yukio Ago
- Laboratory of Biopharmaceutics, Osaka University, Suita, Osaka, Japan
- Eijiro Miyako
- Graduate School of Advanced Science and Technology, Japan Advanced Institute of Science and Technology, Nomi, Ishikawa, Japan
- DOI
- https://doi.org/10.1021/jacsau.4c00311
- Journal volume & issue
-
Vol. 4,
no. 8
pp. 2811 – 2817
Abstract
No abstracts available.